John Mattone Global
John Mattone, Bestselling Author and the World's #1 Executive Coach
SANFORD, FL / ACCESSWIRE / February 20, 2024 / John Mattone has been selected as the World's #1 Executive Coach and Coaching Authority for the fifth time in the past six years by the research organization Globalgurus.org. Dr. Peter Chee was #2 and Tony Robbins was #3. As a bestselling author and globally renowned coach, speaker, and educator, John Mattone will be honored at the 2024 Annual Gala in Bali by Global Gurus.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.John Mattone has been selected as the World's #1 Executive Coach and Coaching Authority for the fifth time in the past six years
As a reputable research organization, Global Gurus first honored Mattone in July 2019 at the Annual Gala in Toronto. While inclusion in the Global Gurus Top 30 Global Coaches is an honor in itself, being distinguished as the world's best professional executive coach for three consecutive years, and five out of the past six years, is a very special honor. This selection is based on professional accomplishments, contributions to the field of coaching, leadership, research, peer respect, and pioneering thought leadership.
John Mattone is the founder of one of the world's leading coaching and leadership development firms, John Mattone Global (JMG). JMG is also an industry-leading coach certification company that provides ICF-approved and accredited certification programs to coaches and leaders through its trademarked and licensed brand, Intelligent Leadership. John Mattone Partners, Inc. (JMP) owns an industry-leading 15 registered IP trademarks awarded by the USPTO.
John Mattone is the pioneer of Intelligent Leadership (IL), a transformative, results-oriented leadership growth philosophy and process that ignites, cultivates, and polishes an individual's heart, mind, and soul in support of creating exceptional leadership and cultural capability in an organization. The IL "movement" began in 2010. Since then, John Mattone's IL coaching system has transformed the lives of nearly one million people and impacted the success of thousands of organizations from every corner of the globe - 55 countries to date.
Since 2017, John Mattone has personally coached and mentored over 750 global executive coaches and 45 of the world's top CEO's and government leaders. John Mattone is the former executive coach to the late Steve Jobs and the former legendary CEO of PepsiCo, Roger Enrico.
John is the author of 10 books, including five best-sellers: Talent Leadership (2012), Intelligent Leadership (2013), Cultural Transformations (2016), The Intelligent Leader (2019), and The Executive Coach's Handbook (2022).
John has a Bachelor of Science in Management & Organizational Behavior as well as a Master of Science and Ph.D. in Industrial/Organizational Psychology. He serves on the Dean's Advisory Board (College of Sciences) at the University of Central Florida (UCF) and is a Distinguished Senior Fellow at the Hult International School of Business.
John Mattone and his family are paying it forward through two scholarships at the University of Central Florida: The John Mattone Endowed Graduate Scholarship Fund for Executive Coaching and Leadership (for Graduate students in Industrial/Organizational Psychology) and The Mattone Family Endowed Scholarship for Industrial/Organizational Psychology.
About John Mattone
John Mattone is a bestselling author, the world's #1 authority on Intelligent Leadership and one of the world's most in-demand CEO coaches and leadership speakers. He is the founder of John Mattone Global, one of the world's leading executive coaching firms.
For more information, please visit http://www.johnmattone.com and http://www.ilmovement.com.
Contact Information
Manny Janero
Marketing Manager
info@clickelements.com
1.866.923.5464
SOURCE: John Mattone Global
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Volatus Aerospace Welcomes UK-Based Air Data Systems to its Ecosystem, Expanding Global Capabilities11.12.2024 07:45:00 CET | Press release
TORONTO, ON / ACCESSWIRE / December 11, 2024 / Volatus Aerospace Inc. (TSXV:FLT)(OTCQX:TAKOF)(FSE:ABBA) is pleased to announce the integration of key assets and capabilities from Air Data Systems (ADS), based in the United Kingdom, marking a strategic expansion of its global aerial solutions ecosystem. This collaborative arrangement strengthens Volatus' position as a leader in aerial intelligence and logistics by opening doors to new opportunities and partnerships in critical industries. ADS specializes in streamlining large-scale and complex surveys and data acquisition projects for industrial applications such as asset management, inspection services, oil & gas, utilities, and environmental services. The transaction, structured with a success-fee model tied to future contract outcomes, aligns the interests of both organizations and highlights the significant potential of this collaboration. As part of this agreement, Volatus has acquired the ADS brand, website, and domain, along with
Loar Announces Pricing of Upsized Public Offering10.12.2024 23:40:00 CET | Press release
WHITE PLAINS, NY / ACCESSWIRE / December 10, 2024 / Loar Holdings Inc. (NYSE:LOAR) ("Loar"), announced today the pricing of its upsized public offering of 5,750,000 shares of its common stock, including 1,897,500 shares offered by certain stockholders and 3,852,500 shares offered by Loar at $85.00 per share. The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 862,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on December 12, 2024, subject to customary closing conditions. Loar intends to use the net proceeds from this offering for repayment of borrowings outstanding under its credit agreement and, to the extent of any remaining proceeds, for general corporate purposes, including working capital. Loar will not receive any of the proceeds from the sale of common stock offered by the selling stockholders, including any common stock sold pursuant to any
PHYLA Announces a Series of International Collaborations With the University of Bradford and UPM and a Significant Government-Supported Land Regeneration Project in the Gambia10.12.2024 14:00:00 CET | Press release
LONDON, UK PHYLA and the University of Bradford join forces to develop marketable compounds, cosmetics and superfood products from the pongamia plant PHYLA has entered into a commercial agreement with the University of Bradford to develop marketable bio-compounds for cosmetics and superfood products derived from the pongamia (oil tree) plant which are cultivated in PHYLA's land regeneration projects. The partnership aims to leverage PHYLA's existing IP by applying specific extraction technologies which maximise the yield and value of bio-compounds and other plant-based products. Phyla's Pongamia Pods Phyla's high-density pongamia pod cluster Professor Anant Paradkar, Director of The Centre for Pharmaceutical Engineering Science (CPES) at the University of Bradford, commented: "We are thrilled to collaborate with PHYLA to advance the development of plant-based products. Our Centre has a long-standing commitment to green and sustainable extraction technologies, and this partnership align
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections10.12.2024 07:30:00 CET | Press release
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI). VisiRose, a newly launched company of Provectus Biopharmaceuticals (OTCQB:PVCT) and the University, is focused on commercializing this innovative ocular research by combining a formulation of Provectus's pharmaceutical-grade bioactive synthetic small molecule Rose Bengal Sodium (RBS) and BPEI's light-based medical device to treat eye infections caused by bacteria, fungi, and parasites. RB PDAT offers a potential solution to the growing global problem of antimicrobial resistance (AMR), providing a broad-spectrum ocular thera
Young Girl Discovers a 3,500-year-old Egyptian Amulet9.12.2024 07:40:00 CET | Press release
During a family trip near an archaeological site in Hod Hasharon, 12-year-old Dafna Filshteiner found an ancient scarab. LONDON, UK / ACCESSWIRE / December 9, 2024 / Dafna Filshteiner, age 12, was recently hiking below the ancient site of Tel Qana in Hod Hasharon, when suddenly, to her surprise, she discovered an unusual find a beetle-like stone used as an Egyptian amulet about 3,500 years ago. "I was looking down at the ground to find porcupine needles and smooth pebbles," she says. "And suddenly I picked up an interesting stone. I showed it to my mother, and she said it was just an ordinary stone or a bead. But then I saw a decoration and stubbornly insisted it was more than that, so we searched on the Internet. There, we identified more photos of stones similar to what we had found. We realized that it was something special and immediately called the Antiquities Authority." The family turned to Mor Wiesel, an archaeologist at the Israel Antiquities Authority, who thanked Dafna and h
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom